- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Gland Pharma Limited — Board Meeting, 03-11-2025: Outcome of Board Meeting
03-11-2025 | 04:32 pm
03-11-2025 | 04:32 pm
Gland Pharma's Board approved consolidated financial results. Q2 revenue rose 6% YoY to ₹1,486.9 Cr, PAT grew 12% to ₹183.7 Cr. H1 saw 7% revenue growth to ₹2,992.5 Cr, PAT jumped 30% to ₹399.2 Cr. New US product launches and increased GLP-1 capacity indicate strategic growth.
No comments yet. Be the first to comment!